# Evaluation of MST-188 in Acute Lower Limb Ischemia

> **NCT02093468** · PHASE2 · TERMINATED · sponsor: **Mast Therapeutics, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Acute Limb Ischemia

## Interventions

- **DRUG:** MST-188
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02093468
- **Lead sponsor:** Mast Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Program discontinued to persue alternate indications.
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093468, "Evaluation of MST-188 in Acute Lower Limb Ischemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02093468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*